A new report by INSEAD and Booz & Company says that Middle East healthcare sector, including biotech and pharmaceuticals, is expected to yield the most substantial investment opportunities in the near term. The report, titled Private Equity in the Middle East: A Rising Contender in Emerging Markets, adds that the healthcare sector in the region has been 'characterised by underinvestment for several decades, and countries like Kuwait have not built a new hospital in over 20 years'. "Given that spending on healthcare in the GCC region is expected to increase fourfold from $15bn in 2008 to $60bn in 2025, and given also that the cost of providing ongoing healthcare services is largely carried by the state, there is substantial scope for PE to take advantages of opportunities in the healthcare sector," the report said.
You might also like...
Ruwais LNG full EPC award expected in June
29 March 2024
PIF entity makes $1bn Lucid placement
29 March 2024
Petro Rabigh awards KBR maintenance contract
29 March 2024
Diriyah Company seeks firms for demolition work
29 March 2024
A MEED Subscription...
Subscribe or upgrade your current MEED.com package to support your strategic planning with the MENA region’s best source of business information. Proceed to our online shop below to find out more about the features in each package.